iGMDRD174
Canonical SMILES: CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
InChI: InChI=1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+/m1/s1
InChI Key: DEQANNDTNATYII-OULOTJBUSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameOctreotide CHEMBLCHEMBL1680 Pubchem CID448601 KEGG Drug IDD06495 DRUGBANK IDDB00104 Drug StatusAlone Drug targets (TTD)DAP000397 Drug TypeSmall Molecule |
Drug Class:
Amino Acids, Peptides, and ProteinsAntineoplastic AgentsAntineoplastic Agents, HormonalBradycardia-Causing AgentsGastrointestinal AgentsHyperglycemia-Associated AgentsHypoglycemia-Associated AgentsHypothalamic HormonesMacrocyclic CompoundsMiscellaneous Therapeutic AgentsP-glycoprotein/ABCB1 SubstratesPeptidesPeptides, CyclicPituitary and Hypothalamic Hormones and AnaloguesPolycyclic CompoundsPotential QTc-Prolonging AgentsQTc Prolonging AgentsSomatostatin and AnaloguesSystemic Hormonal Preparations, Excl. Sex Hormones and InsulinsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Loading, please wait...
Gene ID | Gene Name | Model Num. |
---|---|---|
4771 | NF2 | 2 |
Showing 1 to 1 of 1 rows
Gene in drug-gene network: Network Plot

Models in Octreotide
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |